RheumaGen

Aurora, United States

Last funding

Undisclosed

Series ADec 2025

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

Backed bySPRIM Global InvestmentsBeyond Celiac InvestmentsWilliam Taylor Nominees

About RheumaGen

Who are RheumaGen's investors?

RheumaGen's investors include SPRIM Global Investments, Beyond Celiac Investments, William Taylor Nominees.

Where is RheumaGen headquartered?

RheumaGen is headquartered in Aurora, United States.

What does RheumaGen do?

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

What stage is RheumaGen at?

RheumaGen is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 22, 2025.

MLA

"RheumaGen — Funding & Investors." VCBacked, December 22, 2025, https://www.vcbacked.co/company/rheumagen. Accessed September 30, 2026.

APA

VCBacked. (2025). RheumaGen — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/rheumagen

Wikipedia (cite web)

{{cite web |title=RheumaGen — Funding & Investors |url=https://www.vcbacked.co/company/rheumagen |website=VCBacked |access-date=September 30, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated December 22, 2025

Founder contacts

m***@rheumagen.com

linkedin.com/in/●●●●●●

Emails, phones & LinkedIn · 41,000+ verified contacts

Similar in BiotechnologyView all